“…26 HEC1A, RL95-2 (RL95) endometrial carcinoma, and HT29 colon carcinoma cell lines (all from American Type Culture Collection, Rockville, MD) were cultured as described previously. 6,23 Epidermal growth factor (EGF; Calbiochem, La Jolla, CA) or HGF/SF (R&D Systems, Minneapolis, MN) treatments (each at 20 ng/ml) were incubated for the indicated time with RL95 cells that had been serum-starved for 12 hours. Melanoma cell lines, MUM-2B, MUM-2C, C918, C8161, and A375P, were maintained in RPMI 1640 medium (Life Technologies, Inc., Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum (Life Technologies, Inc., Invitrogen), 20 mmol/L HEPES, and 0.1% gentamicin sulfate.…”